In response to oxidative stress, Nrf2 and p21 
INTRODUCTION
The transcription factor Nrf2 has emerged as a master regulator of an intracellular antioxidant response through transcriptional activation of an array of genes, including phase II detoxifying enzymes, antioxidants, and transporters that protect cells from toxic and carcinogenic chemicals (Kensler et al., 2007; Kobayashi and Yamamoto, 2005; Zhang, 2006) . Nrf2-deficient mice are prone to chemical-induced toxicity and tumorigenesis (Aoki et al., 2001; Cho et al., 2004; Lau et al., 2008; Ramos-Gomez et al., 2001) . The Nrf2 signaling pathway is negatively controlled by Keap1. Keap1 contains several domains that are essential for its functions: the BTB domain is required for homodimerization, the linker domain contains several cysteine residues that sense intracellular redox imbalance, and the Kelch domain binds the N-terminal Neh2 domain of Nrf2 (Itoh et al., 1999; Wakabayashi et al., 2004; Yamamoto et al., 2008; Zhang and Hannink, 2003; Zipper and Mulcahy, 2002) . Under basal conditions, Keap1, functioning as a substrate adaptor for a Cul3-based E3 ubiquitin ligase, constantly targets Nrf2 for ubiquitin-dependent degradation to maintain low levels of Nrf2 (Itoh et al., 1999; Kobayashi et al., 2004 Kobayashi et al., , 2006 McMahon et al., 2003; Zhang and Hannink, 2003; Zhang et al., 2004) . Very recently, a two-site substrate recognition model, also called the hinge and latch model, was presented to explain how Keap1 recruits Nrf2 and assists in ubiquitination of Nrf2 (McMahon et al., 2006; Tong et al., 2006 Tong et al., , 2007 . It is believed that the Keap1 homodimer binds both the 29 DLG and 79 ETGE motifs in Nrf2 to align the seven ubiquitin-accepting lysine residues between these motifs into a conformation suitable for ubiquitin conjugation (McMahon et al., 2006; Tong et al., 2006 Tong et al., , 2007 Zhang et al., 2004) . Upon oxidative stress, modification of the cysteine residues on Keap1, such as C151, C273, or C288 in the BTB or linker domain, imposes a conformational change that disrupts the weak Kelch-29 DLG binding, resulting in diminished Nrf2 ubiquitination without dissociation of Nrf2 from Keap1 (McMahon et al., 2006; Tong et al., 2006 Tong et al., , 2007 . As a consequence, Nrf2 protein levels are increased, and the Nrf2 signaling pathway is activated (Itoh et al., 1999; Kobayashi et al., 2004 Kobayashi et al., , 2006 McMahon et al., 2003; Zhang and Hannink, 2003; Zhang et al., 2004) . p21 Cip1/WAF1 regulates many cellular processes such as cellcycle arrest, DNA replication and repair, cell differentiation, senescence, and apoptosis (Dotto, 2000; Gartel and Tyner, 2002; Li et al., 1994; O'Reilly, 2005) . In response to oxidative stress, p21 is upregulated to promote cell survival (Esposito et al., 1998; Gartel and Tyner, 2002; O'Reilly et al., 2001; Poon and Hunter, 1998) . However, the underlying mechanism by which p21 protects cells from oxidative damage remains unclear. In this report, we present molecular and genetic evidence suggesting that p21-dependent cell survival under oxidative stress is mediated through activation of the Nrf2 signaling pathway. The protein level of Nrf2 is upregulated by p21 through direct interaction between p21 and Nrf2. The interacting motifs have been mapped to the 29 DLG and 79 ETGE motifs in Nrf2 and the 154 KRR in p21. p21 activates the Nrf2 pathway by competing with Keap1 for Nrf2 binding, particularly through the 29 DLG motif, compromising the Keap1-dependent ubiquitination of Nrf2. Furthermore, p21-mediated upregulation of Nrf2 under both basal and induced conditions was confirmed using p21-deficient mice, demonstrating the physiological significance of our findings.
RESULTS

Nrf2
Was Required for the p21-Dependent Cellular Protection in Response to Oxidative Stress To determine a possible functional link between p21 and Nrf2, a series of experiments were performed in mouse embryonic fibroblasts (MEFs) from Keap1-or Nrf2-deficient mice, or in HCT116 cells with or without a somatic p21 deletion. First, the protective role of p21 against the cellular stress response was verified by measuring intracellular reactive oxygen species (ROS) Figure 1A ).
To exclude the possibility that the difference in their response to H 2 O 2 is due to clonal artifacts, p21-cDNA was reintroduced into HCT116-p21 À/À cells by transient transfection. Ectopic expression of p21 rescued HCT116-p21 À/À cells from H 2 O 2 -induced ROS production ( Figure 1A ). The residual dose-dependent increase of ROS is likely due to the fact that 100% transfection efficiency could not be achieved. Next, the antioxidant function of Nrf2 was demonstrated in HCT116-p21 +/+ cells using a siRNA approach. Nrf2-siRNA significantly reduced Nrf2 protein level, compared with the control siRNA ( Figure 1B) . Consequently, Nrf2-siRNA-transfected cells had an elevated basal ROS level compared to the control-siRNA-transfected cells ( Figure 1B ). In addition, the antioxidant response mediated by p21 and by Nrf2 was further evaluated by comparing the survival curves in response to H 2 O 2 treatment between the pair of HCT116-p21 cells (data not shown). Interestingly, similar toxicity curves were obtained between these two groups (see Figure S1 available Figure 2A ). p21-siRNA had no effect on the mRNA expression of Nrf2 or Keap1, while knockdown of p21 expression resulted in a decrease of the Nrf2-dependent transcription of NAD(P)H quinone oxidoreductase 1 (NQO1) and heme oxygenase-1 (HO-1) in MEF-Nrf2 +/+ cells ( Figure 2A ). In contrast, p21
siRNA had no effect on transcription of NQO1 or HO-1 in MEFNrf2 À/À cells ( Figure 2B ). Together, these data indicate that p21-mediated upregulation of the Nrf2 signaling pathway requires Nrf2. This notion was further verified by overexpression of p21 in HCT116-p21 À/À cells. Transient expression of p21 enhanced the levels of Nrf2 protein in a p21 dose-dependent manner ( Figure 2C ). Consistent with the increased protein level of Nrf2, the transcriptional activity of Nrf2 was also enhanced by overexpression of p21 when a NQO1-ARE firefly luciferase reporter was used (Figure 2C ). Therefore, p21 is able to activate the Nrf2 signaling pathway by enhancing Nrf2 protein levels. A similar experiment was also performed in COS-1 cells; coexpression of p21 with Nrf2 enhanced the protein level of Nrf2 in the absence or presence of exogenous Keap1, and overexpression of Keap1 decreased the protein level of Nrf2 as expected ( Figure S2 ).
HCT116-p21
À/À Cells Had Reduced Basal and Induced Levels of the Nrf2-Dependent Antioxidant Response It has been well documented that p21 is induced in both a p53-dependent and -independent manner at the transcriptional and posttranscriptional levels in response to oxidative stress. The endogenous p21 level was measured in HCT116-p21 +/+ cells treated with Nrf2 activators, tert-butylhydroquinone (tBHQ), and sulforaphane (SF). Both tBHQ and SF are able to induce p21 protein levels in a dose-dependent manner ( Figure 3A) . Next, the Nrf2-dependent response under basal and induced conditions in HCT116-p21 +/+ and HCT116-p21 À/À cells was compared. First, the basal level of Nrf2 is slightly lower in HCT116-p21 À/À cells ( Figure 3B ). tBHQ and SF enhanced the protein level of Nrf2 in both cell lines, although the Nrf2 level (C) p21 upregulated the ARE-reporter gene activity. HCT116-p21 À/À cells were transfected with different amounts of p21 expression vectors, along with expression vectors for the NQO1-ARE firefly luciferase and TK-renilla luciferase. The protein levels of p21 and Nrf2 were detected with anti-p21 and anti-Nrf2 antibodies (lower panels). The firefly luciferase activities were normalized to renilla luciferase activities, and the standard deviations were calculated from three independent experiments, each with duplicate samples; *p < 0.05 compared with its control.
was consistently lower in HCT116-p21 À/À cells compared to that in HCT116-p21 +/+ ( Figure 3B ). Second, the Nrf2 transcriptional activity is consistently lower under both basal and induced conditions in HCT116-p21 À/À cells, compared to HCT116-p21 +/+ cells, when the NQO1-ARE-dependent firefly luciferase reporter was used ( Figure 3C ). In addition, tBHQ or SF markedly enhanced the ARE-luciferase activity in HCT116-p21 +/+ cells; however, only moderate inductions were observed upon treatment in HCT116-p21 À/À cells, indicating an additive effect of p21 and oxidative stress in activating Nrf2 ( Figure 3C ). A similar result was obtained by using a glutathione S-transferase (GST)-ARE firefly luciferase reporter ( Figure S3 ). Third, the mRNA expression of Nrf2 and several Nrf2 target genes was measured by qRT-PCR. No significant difference was detected in Nrf2 mRNA expression in any of the conditions between these two cell types, which is consistent with the result demonstrating that p21 siRNA had no effect on Nrf2 mRNA expression in MEF-Nrf2 +/+ cells ( Figure S4 and Figure 2A ). However, mRNA expression of NQO1, glutathione peroxidase 2 (Gpx2), and multidrug resistance protein 2 (Mrp2) was increased by the Nrf2 activators in both cell types ( Figure 3D ). Furthermore, the basal level and the induction fold of these genes were lower in HCT116-p21 À/À cells compared to HCT116-p21 +/+ cells ( Figure 3D ). Lastly, in correlation with the lower level of NQO1 mRNA in HCT116-p21 À/À cells, the enzymatic activity of NQO1 was also reduced in HCT116-p21 À/À cells, compared to HCT116-p21 +/+ cells ( Figure 3E ). These results clearly demonstrate that p21 is able to activate the Nrf2 signaling pathway by enhancing Nrf2 protein levels.
p21 Directly Interacted with Nrf2
The interaction of these two proteins was explored in vivo and in vitro. p21-Myc and HA-Nrf2 were transiently expressed in COS-1 cells. p21-Myc was detected in the HA immunoprecipitates ( Figure 4A , left panel). In a reciprocal immunoprecipitation assay, HA-Nrf2 was present in the Myc immunoprecipitates ( Figure 4A , right panel), indicating the presence of both p21 and Nrf2 in the same complex in vivo. To test direct binding and to identify the Nrf2-binding domain in p21, a series of GST-tagged p21 deletion mutants were purified and incubated with the 35 S-labeled Nrf2 protein. Direct interaction of these two proteins was detected ( Figure 4B, lanes 1-164) . Based on the fact that p21 70-140 lost interaction with Nrf2, whereas p21 70-164 did not, it was deduced that the C-terminal domain of p21 containing 24 amino acids (from 140-164) is likely to be the interaction site for Nrf2 binding ( Figure 4B ). Reciprocally, GST-tagged Nrf2 was also able to pull down 35 S-labeled p21 protein, but not the negative control luciferase ( Figure 4C ). To identify the p21-binding domain in Nrf2, an immunoprecipitation analysis was performed with cell lysates coexpressing p21-Myc and each of the several HA-Nrf2 deletion mutants. All mutants retained their ability to bind p21, including the smallest one (the N-terminal 1-115), indicating that this N-terminal domain (1-115) contains a binding site for p21 ( Figure 4D ). More importantly, the interaction of endogenous Nrf2 with endogenous p21 was assessed in HCT116-p21 +/+ and MEF-Nrf2 +/+ cells. The antip21 antibody, but not IgG or HA, immunoprecipitated Nrf2 in both HCT116-p21 +/+ and MEF-Nrf2 +/+ cells (Figure 4E and Figure S5) . Furthermore, there was an increased association of p21 with Nrf2 in response to oxidative stress, likely due to increased expression of Nrf2 and p21 in response to tBHQ treatment ( Figure 4E ). These results suggest that p21 upregulates the Nrf2 signaling pathway mainly through direct interaction with Nrf2 to enhance the protein level of Nrf2. Figure 4D ). The N-terminal Neh2 domain of Nrf2 contains many functional motifs or residues that have been reported to be important for the function of Nrf2. In particular, it contains seven lysine residues that are required for ubiquitination and degradation of Nrf2. It also contains two Keap1-binding motifs, 29 DLG and 79 ETGE, that are crucial for Keap1-dependent ubiquitination and degradation of Nrf2. To further narrow down the precise amino acid residues in the Neh2 domain of Nrf2 that interact with p21, two Nrf2 mutants were generated: mDLG and mETGE in which the 29 DLG or 79 ETGE motif was replaced with alanine residues.
Immunoprecipitation analyses were performed in COS-1 cells cotransfected with p21-Myc and Nrf2 wild-type or each of its mutants. In order to compare the binding affinity of Nrf2 to p21 with that of Nrf2 to Keap1, Nrf2 wild-type or each of its mutants was also coexpressed with the Kelch domain of Keap1 in another set of experiments. Both sets of samples were prepared and analyzed together using the immunoprecipitation/immunoblot method. Since mutation of 29 DLG or 79 ETGE affects Keap1 binding to Nrf2, and, therefore, the stability of the Nrf2 proteins, the expression levels of Nrf2, mDLG, and mETGE differed significantly when equal amounts of Nrf2 were transfected. For that reason, the amounts of Nrf2 were adjusted to give rise to similar levels of Nrf2 protein in the total lysates ( Figure 5A , lower panels). p21-Myc and Kelch-Myc were expressed at comparable levels when the total lysates were analyzed with an anti-Myc antibody ( Figure 5A , lower antiMyc panel). All the lysates were immunoprecipitated with an anti-Nrf2 antibody, and the immunoprecipitated proteins were subjected to immunoblot analysis with anti-Myc for detection of p21-Myc and Kelch-Myc, and anti-HA to detect HA-Nrf2 ( Figure 5A , upper panels). In agreement with the two-site model reported previously, mutation of 79 ETGE significantly diminished the Nrf2-Kelch interaction while replacement of 29 DLG with AAA weakened Nrf2 binding slightly ( Figure 5A , compare lanes 8 and 7 with lane 6). Interestingly, the association of p21 to either of the Nrf2 mutants was weaker compared to Nrf2 wild-type, indicating that both 29 DLG and 79 ETGE are the interacting motifs for p21
( Figure 5A , compare lanes 3 and 4 with lane 2). It seems that the binding affinities of Nrf2-p21 and Nrf2-Kelch were comparable since similar amounts of p21-Myc and Kelch-Myc were immunoprecipitated by an anti-Nrf2 antibody. In contrast, the binding was weaker for mETGE to Kelch than mETGE to p21 ( Figure 5A , compare lane 8 with lane 4), indicating that p21 may readily compete with Keap1 for the 29 DLG site (latch).
Next, a competition assay was carried out to examine if p21 is able to displace Keap1. Since ectopic coexpression of p21 changes Nrf2 levels, it is impossible to express equal amounts of Nrf2 among samples when different amounts of p21 are expressed. Therefore, the competition assay between p21 and Keap1 for Nrf2 binding was performed in vitro. HA-Nrf2, chitinbinding domain (CBD)-tagged Keap1, or p21-Myc was individually transfected into COS-1 cells. The same amount of lysate containing HA-Nrf2 and CBD-Keap1 was mixed with an increasing amount of p21-Myc lysate. The untransfected COS-1 lysate was used to match the total volume of the mixture. Keap1-containing complexes were pulled down by chitin beads and subjected to immunoblot analysis with anti-HA and anti-CBD antibodies. Our results show that p21 is inefficient in dissociating the Nrf2-Keap1 complex ( Figure S6 ). We reasoned that p21 is probably able to compete for 29 À/À cells ( Figure 5B ). As expected, tBHQ was able to reduce ubiquitination of Nrf2 in both cell lines ( Figure 5B) . Next, the half-life of Nrf2 in HCT116-p21 +/+ cells was compared to that in HCT116-p21 À/À cells by using cycloheximide (CHX) and immunoblot analysis. Nrf2 had a longer half-life in HCT116-p21 +/+ cells than in HCT116-p21 À/À cells (27.9 min versus 14.4 min in the untreated condition; 45.3 min versus 23.9 min in the tBHQ-treated condition) ( Figure 5C ). A similar result was obtained when a pulse-chase 35 S-labeling method was utilized for measurement of the half-life of Nrf2 ( Figure S7 ). Taken together, our data indicate that p21 is able to prevent ubiquitination of Nrf2 by disrupting the latch site ( et al., 2006, 2007) . Since p21 does not have a rigid structure, but binds to the same 29 DLG or 79 ETGE motif as does Kelch, it is possible that basic amino acid clusters consisting of arginine/lysine residues may be the Nrf2 interaction site in p21. In addition, the result from the GST pull-down experiment demonstrates that the 24 amino acids (140-164) in the C terminus of p21 contained the Nrf2 binding site(s) ( Figure 4B ). Hence, we examined the arginine/lysine clusters within the 24 amino acids. Three clusters,
140
RKRR, 154 KRR, and 161 KRK, were found. Accordingly, three p21 mutants (mRKRR, mKRR, and mKRK) were constructed in which arginine or lysine residues were replaced with methionine residues. Next, p21 wild-type (WT) or each of its mutants was coexpressed with HA-Nrf2 in COS-1 cells for immunoprecipitation analysis. Expression of p21 wild-type or its mutants was roughly equal ( Figure 6A , lower panel). Remarkably, the Nrf2 level in the presence of mKRR was significantly lower and was comparable to the Nrf2 level in the absence of exogenous p21, while p21-WT or the other p21 mutants markedly enhanced the protein levels of Nrf2 ( Figure 6A , lower panel, compare lanes 4 and 6 with other lanes). The result of the immunoprecipitation analysis indicates that mKRR lost interaction with Nrf2 ( Figure 6A , upper panel, lane 4). Next, modulation of the Nrf2 transcriptional activity by p21 or its mutants was assessed in COS-1 cells. In concordance with the protein level of Nrf2, cotransfection of p21-WT, mRKRR, or mKRK significantly increased the luciferase activity ( Figure 6B ). In contrast, cotransfection of mKRR had no effect on the luciferase activity that was similar to the vector-cotransfected sample ( Figure 6B ). Combined with the data shown in Figure 5 , these results demonstrate that direct interaction between Nrf2 and p21 requires the 29 DLG and 79 ETGE motifs in Nrf2 and the 154 KRR cluster in p21. Next, cellular localization of Nrf2 and p21 was examined using indirect immunofluorescence staining. Nrf2 was primarily localized in the cytosol under basal conditions (Figure 6Ca ). tBHQ and SF enhanced nuclear translocation of Nrf2 (Figures  6Ce and 6Ci) . Heterogeneous localization of p21 was observed, and the majority of cells had both cytoplasmic and nuclear localization (Figures 6Cb, 6Cf, and 6Cj) . In untreated cells, p21 and Nrf2 colocalized primarily in the cytoplasm, whereas in treated cells, there was more overlap staining in the nucleus, primarily due to enhanced nuclear translocation of Nrf2 (Figures 6Cd,  6Ch , and 6Cl). Localization of ectopically expressed p21 and Nrf2 was also determined. Ectopically expressed p21-WT had a similar staining pattern as did endogenous p21, i.e., whole cell or whole cell with more nuclear staining (Figure 6Db ). mRKRR shifted staining more to the cytoplasm, resulting in whole-cell staining (Figure 6Df ). Since 140 RKRR has been identified as a classical nuclear localization signal (NLS) of p21 (Child and Mann, 2006; Dotto, 2000) , and also since the size of p21 allows it to pass through the nuclear pore without the assistance of nuclear transporters, the slight shift to more cytoplasmic localization of mRKRR is expected. Interestingly, mKRR had a similar localization pattern as mRKRR (Figures 6Df and 6Dj) . At this point, the reason for this is still unclear. It may represent another part of the NLS, since most classical NLSs are bipartite, meaning that two clusters of the basic amino acids are separated by several amino acids. mKRK had a cytoplasmic localization with a punctate staining pattern (Figure 6Dn ). These data suggest that p21 mutants with more cytoplasmic localization are still capable of stabilizing Nrf2, except mKRR, which lost interaction with Nrf2. Therefore, it is most likely that competing with Keap1 for 29 DLG binding occurs in the cytosol. This fits well with the established notion that Keap1-mediated Nrf2 ubiquitination and degradation occur in the cytosol.
p21-Deficient Mice Had Reduced Basal and Induced Levels of Nrf2 and Nrf2 Target Genes p21-dependent Nrf2 upregulation under physiological conditions was confirmed using liver tissue from p21-deficient and p21 wild-type control mice that were either untreated or treated with tert-butylhydroxyanisole (BHA). BHA is metabolized into tBHQ following absorption and is a known chemical inducer of oxidative stress in animals (Hayes et al., 2000) . As shown in Figure 7A , the basal Nrf2 level was slightly lower in p21-deficient mice than in wild-type mice. Strikingly, the protein level of Nrf2 enhanced by BHA was substantial in wild-type mice, whereas BHA enhanced Nrf2 to a lesser extent in p21-deficient mice (Figure 7A) . Consistent with the Nrf2 protein level, both NQO1 and HO-1 had lower basal and induced levels in p21-deficient mice, compared to p21 wild-type mice ( Figure 7A ). The induction of the Nrf2-dependent antioxidant response appears to be more substantial in animal models than in cultured cells. Collectively, these results provide solid evidence that upregulation of the Nrf2 antioxidant response by p21 under both basal and induced conditions does not only occur in cell models but also under physiological conditions in animals.
DISCUSSION
In this report, we present our finding that p21 is able to upregulate the Nrf2 signaling pathway under both basal and induced conditions through direct interaction with Nrf2. Based on the genetic and molecular data obtained, we present a model that best explains how p21 is able to upregulate the Nrf2-dependent antioxidant response under both basal and induced conditions ( Figure 7B ). Keap1, an E3 ubiquitin ligase, constantly targets Nrf2 for ubiquitination and subsequent degradation under unstressed conditions. The binding of Keap1 to Nrf2 is through a hinge and latch mechanism, in which each Kelch domain from a Keap1 homodimer binds Nrf2 through two binding sites: a weak-binding 29 DLG motif and a strong-binding 79 ETGE motif. Binding of both sites is essential to present the seven ubiquitinaccepting lysine residues of Nrf2 in the correct orientation to accept ubiquitin, and thus targets Nrf2 for degradation. In response to oxidative stress, Keap1 is able to detect an imbalance in intracellular redox homeostasis through modification of its cysteine residues. These modifications alter its conformation and loosen the latch ( 29 DLG-Kelch), which puts p21 in a better position to compete with Keap1 for binding to the 29 DLG motif.
Once the latch is open, the Keap1-dependent ubiquitination of Nrf2 is compromised even though Keap1 still associates with Nrf2 through the hinge ( 79 ETGE). Thus, Nrf2 is stabilized and the Nrf2-dependent cytoprotective genes are expressed under oxidative stress ( Figure 7B ). It is noteworthy that our finding of p21-mediated upregulation of the Nrf2 signaling pathway should not devalue the importance of Keap1 in sensing and regulating Nrf2. Rather, this p21-Keap1 competition model requires the presence of Keap1 and provides solid support of the hinge and latch model. In general, our data indicate that p21 is able to upregulate the Nrf2-dependent antioxidant response more substantially under induced conditions compared to basal conditions. This is most likely due to increased p21 protein levels under induced conditions, leading to additive effects.
p21 is the founding member of the cyclin-dependent kinase inhibitor (CKI) family, which also includes p27 and p57. The N-terminal regions are well conserved among the three members, including the cyclin/CDK-binding motifs (Gartel and Tyner, 2002) . In our study, the Nrf2-interacting motif is mapped to the C-terminal 154 KRR. The C-terminal sequences of the (Child and Mann, 2006; Dotto, 2000; Gartel and Tyner, 2002) . The physiological roles of this pleiotropic protein mainly rely on its cellular localization and its interacting proteins, which determine the ultimate fate of cells, such as proliferation, differentiation, cell-cycle arrest, and apoptosis. Although we did not address the interplay of these putative p21-interacting proteins in this study, the physiological significance of p21 in upregulating the Nrf2-dependent antioxidant response was confirmed in animals. Both the basal and induced Nrf2-antioxidant response was reduced substantially in p21-deficient mice as compared to wild-type. Thus, our finding that p21 upregulates the Nrf2-dependent antioxidant response pathway adds another dimension to the complexity of the p21-mediated signaling network.
EXPERIMENTAL PROCEDURES
Antibodies, Transfection, Animal Treatment, Immunoblot Analysis, and Reporter Gene Assay Anti-Nrf2, anti-Keap1, and anti-p21 (Santa Cruz); anti-HA beads (Sigma); anti-HA (Covance); and chitin beads and the anti-CBD (New England Biolabs) were purchased from commercial sources. Transfection of cDNA was performed with Lipofectamine Plus (Invitrogen). Nrf2-siRNA and p21-siRNA were purchased from QIAGEN. HiPerfect transfection reagent (QIAGEN) was used to deliver siRNA. Male wild-type and p21-deficient mice were purchased from the Jackson Laboratory. Mice at 6 weeks of age were randomly assigned to BHA (350 mg/Kg in corn oil, i.p.) or control group (corn oil, i.p.) and euthanized at 12 hr following administration. Livers were excised and subjected to immunoblot analysis. The detailed procedures are described in the Supplemental Data. Reporter assays were performed by using the Promega DualLuciferase Reporter Gene Assay System according to the manufacturer's instructions.
In Vivo Ubiquitination of Nrf2, GST Pull-Down, and Immunofluorescence Assays To detect endogenous Nrf2 that is ubiquitin conjugated, cells were exposed to 10 mM MG132 (Sigma) for 4 hr prior to lysis. Cell lysates were subjected to immunoprecipitation with an anti-Nrf2 antibody, and precipitated proteins were immunoblotted with an anti-Ub antibody . GST fusion proteins were expressed in E. coli and purified using GST beads (Amersham Biosciences). The 35 S-labeled Nrf2 was generated by an in vitro transcription and translation kit (Promega). Colocalization of Nrf2 with p21 was detected using double-label indirect immunofluorescence with anti-p21 and anti-Nrf2 antibodies for detection of endogenous p21 and Nrf2, with anti-Myc and anti-HA antibodies detecting ectopically expressed p21-Myc and HA-Nrf2 .
Cell Viability and Cell-Death Assays Cell viability was performed by using MTT assay (Wang et al., 2007) . For detection of H 2 O 2 -induced apoptotic cells, two methods were used: (1) transfected cells were treated with H 2 O 2 , and cells with the condensed chromatin were detected according to the reported method (Gong et al., 1999) ; and (2) apoptotic cells were detected using Annexin V-FITC apoptosis detection kit (Sigma) in combination with flow cytometry. (A) p21-deficient mice had reduced basal and induced levels of Nrf2 and Nrf2 target genes. Wild-type or p21-deficient mice (n = 3) were treated with 350 mg/kg BHA for 12 hr through intraperitoneal injection. Liver tissues were subjected to immunoblot analysis with anti-Nrf2, anti-NQO1, anti-HO-1, and anti-GAPDH antibodies.
(B) A model by which p21 upregulates the Nrf2-dependent antioxidant response at both basal and induced conditions. Keap1, an E3 ubiquitin ligase containing the BTB and Kelch domains, constantly targets Nrf2 for ubiquitination and subsequent degradation under basal conditions. The binding of Keap1 to Nrf2 is through a hinge and latch mechanism, in which each Kelch domain from a Keap1 homodimer binds Nrf2 through two binding sites: a weak-binding DLG motif and a strong-binding ETGE motif. Binding of both sites is essential to present the seven ubiquitin-accepting lysine residues of Nrf2 in the correct orientation to accept ubiquitin, which targets Nrf2 for degradation. In response to oxidative stress, Keap1 is able to detect an imbalance in intracellular redox homeostasis through modification of its cysteine residues. The three important cysteine residues, C151, C273, and C288, are labeled. These modifications alter conformation of Keap1 and loosen the latch (DLGKelch), which puts p21 in a better position to compete with Keap1 for binding to the DLG motif. Once the latch is open, the Keap1-dependent ubiquitination of Nrf2 is compromised even though Keap1 still associates with Nrf2 through the hinge (ETGE). Thus, Nrf2 is stabilized and Nrf2-dependent cytoprotective genes are expressed under oxidative stress.
ROS Detection, NQO1 Activity, and qRT-PCR To detecte ROS, cells were treated with H 2 O 2 for 12 hr and incubated with dichlorofluorescein (DCF) (Sigma) before measuring ROS by flow cytometry. NQO1 activity was measured as the dicoumarol-inhibitable fraction of DCPIP reduction described previously (Wang et al., 2007) . Total mRNA extraction and qRT-PCR analysis were performed as described in the Supplemental Data and were reported previously (Wang et al., 2008) .
Protein Half-Life Analysis
The half-life of Nrf2 was measured by using both CHX/immunoblot and pulsechase 35 S-labeling methods as described in the Supplemental Data.
Statistical Analysis
Experiments were conducted in triplicate, and data are shown as mean ± SD. Statistical analysis was performed using two-tailed Student's t tests to compare means. Significance was set at p < 0.05.
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